Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.
Related Posts
RFK Jr. Cancels Meeting of Key Preventive Health Panel
The task force recommends which screenings and other preventive health measures must be covered by insurance.
Peter Buxtun, Who Exposed Tuskegee Syphilis Study, Dies at 86
A Public Health Service employee, he turned whistle-blower after learning of decades-long research involving hundreds of poor, infected Black men…
Moving in Childhood Contributes to Depression, Study Finds
A study of more than a million Danes found that frequent moves in childhood had a bigger effect than poverty…
